Results 241 to 250 of about 445,630 (307)

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen   +4 more
wiley   +1 more source

Congestive heart failure as the presenting form of a giant left atrial appendage aneurysm: a case report. [PDF]

open access: yesEur Heart J Case Rep
Dzebu AS   +4 more
europepmc   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao   +7 more
wiley   +1 more source

A mulberry in female hypertrophic cardiomyopathy. [PDF]

open access: yesOxf Med Case Reports
Imataki O   +3 more
europepmc   +1 more source

Exercise stress cardiomyopathy-a case report. [PDF]

open access: yesEur Heart J Case Rep
Russell PL   +3 more
europepmc   +1 more source

Role of provocation and exercise imaging for the identification of candidates for cardiac myosin inhibitors. [PDF]

open access: yesESC Heart Fail
Erzeel J   +6 more
europepmc   +1 more source

Automatic monitoring of single-wall MAPSE by transesophageal echocardiography for tracking global left ventricular function irrespective of regional hypokinesia: a secondary analysis. [PDF]

open access: yesIntensive Care Med Exp
Yu J   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy